161 related articles for article (PubMed ID: 25672644)
61. A polycystic variant of a primary intracranial leptomeningeal astrocytoma: case report and literature review.
De Tommasi A; Occhiogrosso G; De Tommasi C; Luzzi S; Cimmino A; Ciappetta P
World J Surg Oncol; 2007 Jun; 5():72. PubMed ID: 17587463
[TBL] [Abstract][Full Text] [Related]
62. Genetic differences between neurocytoma and dysembryoplastic neuroepithelial tumor and oligodendroglial tumors.
Fujisawa H; Marukawa K; Hasegawa M; Tohma Y; Hayashi Y; Uchiyama N; Tachibana O; Yamashita J
J Neurosurg; 2002 Dec; 97(6):1350-5. PubMed ID: 12507133
[TBL] [Abstract][Full Text] [Related]
63. Assessment of 1p/19q status by fluorescence in situ hybridization assay: A comparative study in oligodendroglial, mixed oligoastrocytic and astrocytic tumors.
Shukla B; Agarwal S; Suri V; Pathak P; Sharma MC; Gupta D; Sharma BS; Suri A; Halder A; Sarkar C
Neurol India; 2009; 57(5):559-66. PubMed ID: 19934553
[TBL] [Abstract][Full Text] [Related]
64. Correlation between genetic alteration and long-term clinical outcome of patients with oligodendroglial tumors, with identification of a consistent region of deletion on chromosome arm 1p.
Hashimoto N; Murakami M; Takahashi Y; Fujimoto M; Inazawa J; Mineura K
Cancer; 2003 May; 97(9):2254-61. PubMed ID: 12712480
[TBL] [Abstract][Full Text] [Related]
65. Correlation of histology and molecular genetic analysis of 1p, 19q, 10q, TP53, EGFR, CDK4, and CDKN2A in 91 astrocytic and oligodendroglial tumors.
Ueki K; Nishikawa R; Nakazato Y; Hirose T; Hirato J; Funada N; Fujimaki T; Hojo S; Kubo O; Ide T; Usui M; Ochiai C; Ito S; Takahashi H; Mukasa A; Asai A; Kirino T
Clin Cancer Res; 2002 Jan; 8(1):196-201. PubMed ID: 11801559
[TBL] [Abstract][Full Text] [Related]
66. New treatment paradigm for patients with anaplastic oligodendroglial tumors.
Polivka J; Polivka J; Rohan V; Topolcan O
Anticancer Res; 2014 Apr; 34(4):1587-94. PubMed ID: 24692686
[TBL] [Abstract][Full Text] [Related]
67. Chromosome 1p/19q status combined with expression of p53 protein improves the diagnostic and prognostic evaluation of oligodendrogliomas.
Xiong J; Liu Y; Wang Y; Ke RH; Mao Y; Ye ZR
Chin Med J (Engl); 2010 Dec; 123(24):3566-73. PubMed ID: 22166632
[TBL] [Abstract][Full Text] [Related]
68. Diffuse leptomeningeal glioneuronal tumors: a new entity?
Gardiman MP; Fassan M; Orvieto E; D'Avella D; Denaro L; Calderone M; Severino M; Scarsello G; Viscardi E; Perilongo G
Brain Pathol; 2010 Mar; 20(2):361-6. PubMed ID: 19486008
[TBL] [Abstract][Full Text] [Related]
69. Utility of in situ demonstration of 1p loss and p53 overexpression in pathologic diagnosis of oligodendroglial tumors.
Hirose T; Ishizawa K; Shimada S
Neuropathology; 2010 Dec; 30(6):586-96. PubMed ID: 20408960
[TBL] [Abstract][Full Text] [Related]
70. Contribution of 1p, 19q, 9p and 10q Automated Analysis by FISH to the Diagnosis and Prognosis of Oligodendroglial Tumors According to WHO 2016 Guidelines.
Michaud K; de Tayrac M; D'Astous M; Duval C; Paquet C; Samassekou O; Gould PV; Saikali S
PLoS One; 2016; 11(12):e0168728. PubMed ID: 28030632
[TBL] [Abstract][Full Text] [Related]
71. "Primary" leptomeningeal medulloblastoma.
Mehta RI; Cutler AR; Lasky JL; Yong WH; Lerner JT; Hirota BK; Salamon N; Mathern GW; Vinters HV
Hum Pathol; 2009 Nov; 40(11):1661-5. PubMed ID: 19695677
[TBL] [Abstract][Full Text] [Related]
72. [Diffuse Leptomeningeal Glioneuronal Tumor with Subarachnoid Hemorrhage:A Case Report].
Igarashi K; Kawanami K; Yamaki T; Matsuda KI; Komori T; Sonoda Y
No Shinkei Geka; 2020 Sep; 48(9):801-808. PubMed ID: 32938808
[TBL] [Abstract][Full Text] [Related]
73. Extracranial relapse of an anaplastic oligodendroglioma in an adolescent: case report and review of the literature.
Bruggers C; White K; Zhou H; Chen Z
J Pediatr Hematol Oncol; 2007 May; 29(5):319-22. PubMed ID: 17483710
[TBL] [Abstract][Full Text] [Related]
74. Pediatric glioblastoma with oligodendroglioma component: aggressive clinical phenotype with distinct molecular characteristics.
Mizoguchi M; Hata N; Suzuki SO; Fujioka Y; Murata H; Amano T; Nakamizo A; Yoshimoto K; Iwaki T; Sasaki T
Neuropathology; 2013 Dec; 33(6):652-7. PubMed ID: 23530875
[TBL] [Abstract][Full Text] [Related]
75. Successful treatment of low-grade oligodendroglial tumors with a chemotherapy regimen of procarbazine, lomustine, and vincristine.
Stege EM; Kros JM; de Bruin HG; Enting RH; van Heuvel I; Looijenga LH; van der Rijt CD; Smitt PA; van den Bent MJ
Cancer; 2005 Feb; 103(4):802-9. PubMed ID: 15637687
[TBL] [Abstract][Full Text] [Related]
76. Intracerebral rhabdoid and papillary meningioma with leptomeningeal spread and rapid clinical progression.
Al-Habib A; Lach B; Al Khani A
Clin Neuropathol; 2005; 24(1):1-7. PubMed ID: 15696777
[TBL] [Abstract][Full Text] [Related]
77. Granular cells in oligodendroglioma suggest a neoplastic change rather than a reactive phenomenon: case report with molecular characterisation.
Rao S; Sravya P; Chandran C; Saini J; Somanna S; Santosh V
Brain Tumor Pathol; 2017 Jan; 34(1):42-47. PubMed ID: 27738816
[TBL] [Abstract][Full Text] [Related]
78. Leptomeningeal dissemination at diagnosis of pediatric low-grade neuroepithelial tumors.
Hukin J; Siffert J; Cohen H; Velasquez L; Zagzag D; Allen J
Neuro Oncol; 2003 Jul; 5(3):188-96. PubMed ID: 12816725
[TBL] [Abstract][Full Text] [Related]
79. A case of primary diffuse leptomeningeal gliomatosis predominantly involving the cervical spinal cord and mimicking chronic meningitis.
Heijink DS; Urgun K; Sav A; Seker A; Konya D
Turk Neurosurg; 2012; 22(1):90-4. PubMed ID: 22274977
[TBL] [Abstract][Full Text] [Related]
80. A case of diffuse leptomeningeal oligodendrogliomatosis associated with HHV-6 variant A.
Stödberg T; Deniz Y; Esteitie N; Jacobsson B; Mousavi-Jazi M; Dahl H; Zweygberg Wirgart B; Grillner L; Linde A
Neuropediatrics; 2002 Oct; 33(5):266-70. PubMed ID: 12536370
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
